Buy 3-HO-PCP for sale online from USA vendor
Table of Contents
- Introduction to 3-HO-PCP
- History and Culture
- Chemistry
- Pharmacology
- Dosage
- Physical Effects
- Disconnective Effects
- Cognitive Effects
- Auditory Effects
- Visual Effects
- Toxicity and Harm Potential
- Urinary Tract Effects
- Dangerous Interactions
- Legal Status
- FAQ
Understanding 3-HO-PCP
3-Hydroxyphencyclidine (commonly known as 3-HO-PCP) is a unique dissociative substance belonging to the arylcyclohexylamine class. It is renowned for its ability to induce potent dissociative, hallucinogenic, and euphoric effects upon administration. One of its primary mechanisms of action involves acting as a NMDA receptor antagonist. Notably, it has also been found to exhibit considerable affinity for the μ-opioid receptor.
Historical Context and Synthesis
Synthesized for the first time in 1978, the inception of 3-HO-PCP aimed to delve into the structural relationships of phencyclidine (PCP) derivatives. Further research during the 1980s, conducted alongside PCP, unveiled its additional property as a μ-opioid agonist in animal models.
Pharmacological Properties and Effects
Similar to other substances within its class, such as methoxetamine (MXE), PCP, and 3-MeO-PCE, 3-HO-PCP predominantly induces a state known as "dissociative anesthesia." However, the manifestation of its effects appears to be heavily contingent on dosage, with variability reported. Notably, the translation of observed opioid properties in animal models to human physiology remains uncertain, with preliminary indications suggesting a disparity.
Safety Concerns and Risks
Reports suggest that the administration of 3-HO-PCP may lead to pronounced physical side effects, including muscle soreness and flu-like symptoms, either during or shortly after ingestion. This raises concerns regarding its potential for heightened danger or toxicity compared to related dissociatives, particularly at higher doses.
Current Distribution and Recommendations
In contemporary times, 3-HO-PCP is predominantly circulated as a gray area research chemical through online vendors. Despite its availability, scant knowledge is available concerning its pharmacology, metabolism, and toxicity in human subjects. Given its sensitivity to dosage, potential for habit formation, and unknown toxicity profile, it is strongly advised that individuals exercising caution utilize proper harm reduction practices when contemplating the use of this substance.
Understanding Dosage of 3-HO-PCP
Threshold Dosage
The threshold dosage for 3-HO-PCP is approximately 1 mg. This marks the minimum amount required to elicit any discernible effects.
Light Dosage
A light dosage of 3-HO-PCP typically ranges between 2 to 4 mg. At this level, users may experience subtle effects indicative of the substance's influence.
Common Dosage
For a common dosage, individuals typically consume between 4 to 6 mg of 3-HO-PCP. This range is associated with more pronounced effects compared to lighter doses.
Strong Dosage
A strong dosage of 3-HO-PCP falls within the range of 6 to 8 mg. At this level, users can anticipate intensified and potentially overwhelming effects.
Heavy Dosage
Dosing at 8 mg or higher is considered heavy for 3-HO-PCP. Users venturing into this territory should be prepared for profound and potentially adverse effects.
Note on Redosing
It's crucial to note that redosing with 3-HO-PCP can lead to dangerous cumulative effects. The compound's potency and potential for adverse reactions may increase with successive doses. Thus, caution should be exercised to avoid unintended harm or complications.
Exploring the Physical Effects of 3-HO-PCP
Stimulation & Sedation
3-HO-PCP can induce both stimulation and sedation, with effects oscillating between these states.
Restless Legs
Some users may experience restless legs as a physical effect of 3-HO-PCP ingestion.
Spontaneous Bodily Sensations
The compound can evoke spontaneous sensations throughout the body.
Perception of Bodily Lightness
Users might perceive a sense of bodily lightness while under the influence of 3-HO-PCP.
Physical Euphoria
Reports suggest that 3-HO-PCP is more prone to induce euphoria compared to other dissociatives like ketamine or diphenidine.
Tactile Enhancement and Tactile Suppression
At lower dosages, tactile enhancement may occur, while higher doses can lead to tactile suppression and anesthesia.
Pain Relief
In stronger to heavier dose ranges, 3-HO-PCP may offer pain relief akin to nerve-signal blocking anesthetic effects.
Motor Control Loss
Users may experience loss of motor control while under the influence of 3-HO-PCP.
Changes in Felt Gravity
The perception of gravity may alter following ingestion of the compound.
Spatial Disorientation
Prominent at higher doses, spatial disorientation differs from other dissociatives like ketamine.
Cardiovascular Effects
- Abnormal heartbeat
- Increased blood pressure
- Increased heart rate
- Increased perspiration
- Respiratory depression
Olfactory Hallucinations
Users might experience hallucinations related to the sense of smell.
Optical Effects
- Optical sliding
- Appetite suppression
- Dehydration
- Dizziness
- Difficulty urinating
- Orgasm suppression
- Erectile dysfunction
- Seizure (likely in predisposed individuals, especially under taxing conditions)
Disconnective Effects of 3-HO-PCP
Tactile Disconnection
Disconnective effects of 3-HO-PCP are less pronounced compared to other dissociatives, potentially occurring only at higher doses.
Visual Disconnection
Similar to tactile disconnection, visual disconnection may manifest at higher doses.
Consciousness Disconnection
Disconnective effects may extend to consciousness, albeit less prominently than with other dissociatives.
Cognitive Effects of 3-HO-PCP
Anxiety Suppression
3-HO-PCP may suppress feelings of anxiety in users.
Disinhibition
The compound can lead to a state of disinhibition, lowering inhibitory control.
Cognitive Euphoria
Users may experience cognitive euphoria following ingestion.
Compulsive Redosing
Redosing tendencies may be more prevalent with certain routes of administration, such as smoking or vaporization.
Conceptual Thinking
3-HO-PCP might enhance conceptual thinking abilities in users.
Immersion Enhancement
The compound can augment feelings of immersion in activities or experiences.
Creativity Enhancement
Some users may experience heightened creativity under the influence of 3-HO-PCP.
Déjà Vu
Users may encounter sensations of déjà vu while under the influence.
Depersonalization & Derealization
Feelings of detachment from oneself or reality may occur.
Delusion
In some cases, users may experience delusional thinking patterns.
Memory Suppression
The compound may suppress memory formation and recall.
Ego Death
Users might undergo a temporary dissolution of the ego.
Amnesia
Memory impairment may result from 3-HO-PCP use.
Increased Music Appreciation
Some users report heightened appreciation for music while under the influence.
Time Distortion
Perception of time may become distorted.
Thought Connectivity
Connections between thoughts may become more apparent.
Thought Deceleration
The speed of thought processes may slow down.
Thought Disorganization
Thought patterns may become disorganized or fragmented.
Psychosis
In extreme cases or with excessive dosages, psychosis may occur.
Auditory Effects of 3-HO-PCP
Suppression
Auditory sensations may be suppressed.
Distortions
Perceptual distortions may affect auditory experiences.
Hallucinations
Auditory hallucinations may occur, altering perception of sound.
Visual Effects of 3-HO-PCP
Visual Acuity Suppression
The compound may suppress visual acuity.
Double Vision
Users may experience double vision as a visual effect.
Frame Rate Suppression
Visual processing may slow down, affecting the perception of motion.
Pattern Recognition Suppression
Recognition of visual patterns may be impaired.
Distortions
Visual distortions, such as warping or morphing of shapes, may occur.
Perspective Distortions
Perception of depth and spatial relationships may be distorted.
Scenery Slicing
Visual field may appear fragmented or disjointed.
Hallucinatory States
Users may experience visual hallucinations, ranging from simple patterns to complex scenes.
Internal Hallucination
Visual hallucinations may manifest internally, comprising settings, sceneries, and landscapes, among other phenomena.
FAQ (Frequently Asked Questions) about 3-HO-PCP
1. What is 3-HO-PCP?
- 3-HO-PCP, or 3-hydroxyphencyclidine, is a dissociative substance belonging to the arylcyclohexylamine class. It is known for its potent dissociative, hallucinogenic, and euphoric effects.
2. How was 3-HO-PCP discovered?
- 3-HO-PCP was first synthesized in 1978 to explore the structure-activity relationship of phencyclidine (PCP) derivatives. Its μ-opioid agonist activity in animal models was later discovered in the 1980s.
3. What are the physical effects of 3-HO-PCP?
- Physical effects can include stimulation or sedation, restless legs, bodily sensations, euphoria, pain relief, motor control loss, changes in felt gravity, cardiovascular effects, olfactory hallucinations, appetite suppression, and more.
4. Is 3-HO-PCP addictive?
- While evidence is limited, early reports suggest that chronic use of 3-HO-PCP may lead to addiction with potential adverse effects such as psychosis. Tolerance to its effects may develop with prolonged use.
5. How should 3-HO-PCP be used safely?
- It is recommended to exercise extreme caution and harm reduction practices, such as starting with low doses and avoiding multiple consecutive days of use. Volumetric dosing and avoiding compulsive redosing are also advised.
6. What are the potential dangers of combining 3-HO-PCP with other substances?
- Combining 3-HO-PCP with stimulants, depressants, psychedelics, or other dissociatives can increase the risk of adverse psychological reactions, respiratory depression, and other serious consequences.
7. What are the legal implications of 3-HO-PCP?
- The legal status of 3-HO-PCP varies by country. For example, it is classified as a controlled substance in some countries like the UK and Turkey, while in others like Germany, it is not controlled but cannot be sold for human consumption.
8. Are there any known urinary tract effects associated with 3-HO-PCP use?
- Similar to ketamine, repeated and excessive use of 3-HO-PCP may lead to bladder and urinary tract issues, although to a lesser extent due to its higher potency. Symptoms can include urinary frequency, urgency, pressure, pain, hematuria, and incontinence.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics